Robert S. Landsman

Array ( [id] => 9408447 [patent_doc_number] => 20140099699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-10 [patent_title] => 'NON-NATURALLY OCCURRING T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/947580 [patent_app_country] => US [patent_app_date] => 2013-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22810 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13947580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10281636 [patent_doc_number] => 20150166633 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-18 [patent_title] => 'SHORTENED CD95-FC VARIANTS' [patent_app_type] => utility [patent_app_number] => 14/415871 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11635 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340470 [patent_doc_number] => 20150225475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'COMPOSITION COMPRISING A MIXTURE OF CD95-FC ISOFORMS' [patent_app_type] => utility [patent_app_number] => 14/415866 [patent_app_country] => US [patent_app_date] => 2013-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9039 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14415866 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9262151 [patent_doc_number] => 20130344080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'PILR alpha Interactions and Methods of Modifying Same' [patent_app_type] => utility [patent_app_number] => 13/921557 [patent_app_country] => US [patent_app_date] => 2013-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 18324 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13921557 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9197595 [patent_doc_number] => 20130336910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-19 [patent_title] => 'OLFACTORY RECEPTORS INVOLVED IN THE PERCEPTION OF SWEAT CARBOXYLIC ACIDS AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/916282 [patent_app_country] => US [patent_app_date] => 2013-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 19419 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9262140 [patent_doc_number] => 20130344069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'Antigen Binding Proteins that Bind IGF1R' [patent_app_type] => utility [patent_app_number] => 13/916129 [patent_app_country] => US [patent_app_date] => 2013-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23399 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299403 [patent_doc_number] => 08647626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Compositions comprising TNF-specific antibodies for oral delivery' [patent_app_type] => utility [patent_app_number] => 13/912569 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18597 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13912569 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9330109 [patent_doc_number] => 20140056891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-27 [patent_title] => 'TREATMENT OF CANCER WITH ELEVATED DOSAGES OF SOLUBLE FGFR1 FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/913292 [patent_app_country] => US [patent_app_date] => 2013-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18174 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9269148 [patent_doc_number] => 20140024065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-23 [patent_title] => 'EX VIVO METHOD FOR DETERMINING POTENTIAL GLP-2 RECEPTOR MODULATORS' [patent_app_type] => utility [patent_app_number] => 13/910822 [patent_app_country] => US [patent_app_date] => 2013-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 3558 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13910822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10272588 [patent_doc_number] => 20150157584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-11 [patent_title] => 'INHIBITORS OF HIPPO-YAP SIGNALING PATHWAY' [patent_app_type] => utility [patent_app_number] => 14/406749 [patent_app_country] => US [patent_app_date] => 2013-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 48527 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 40 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14406749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13763545 [patent_doc_number] => 10174107 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-01-08 [patent_title] => Antigen binding proteins that bind delta-like 4 (DLL-4) [patent_app_type] => utility [patent_app_number] => 13/903793 [patent_app_country] => US [patent_app_date] => 2013-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 22364 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13903793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9482808 [patent_doc_number] => 08728757 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-20 [patent_title] => 'Methods of modulating cold sensory perception via a cold- and menthol-sensitive receptor (CMR1)' [patent_app_type] => utility [patent_app_number] => 13/902561 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 25 [patent_no_of_words] => 26026 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10898304 [patent_doc_number] => 08921519 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-30 [patent_title] => 'Single chain fusion polypeptides comprising soluble light cytokine domains' [patent_app_type] => utility [patent_app_number] => 13/902328 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 28 [patent_no_of_words] => 13975 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9054015 [patent_doc_number] => 20130251728 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'Method of Treating Stress Hyperglycemia with Human Antibodies to the Glucagon Receptor' [patent_app_type] => utility [patent_app_number] => 13/900275 [patent_app_country] => US [patent_app_date] => 2013-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 42462 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13900275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710891 [patent_doc_number] => 08835459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Sublingual fentanyl spray' [patent_app_type] => utility [patent_app_number] => 13/895111 [patent_app_country] => US [patent_app_date] => 2013-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 29309 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895111 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9710893 [patent_doc_number] => 08835460 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-16 [patent_title] => 'Sublingual fentanyl spray and methods of treating pain' [patent_app_type] => utility [patent_app_number] => 13/895124 [patent_app_country] => US [patent_app_date] => 2013-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 25473 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13895124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12326166 [patent_doc_number] => 09944707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-04-17 [patent_title] => Antibodies that bind epidermal growth factor receptor (EGFR) [patent_app_type] => utility [patent_app_number] => 13/893312 [patent_app_country] => US [patent_app_date] => 2013-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 30295 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10013885 [patent_doc_number] => 09056895 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2015-06-16 [patent_title] => 'Methods of isolating peptides using surface-free affinity purification' [patent_app_type] => utility [patent_app_number] => 13/886978 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5740 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343517 [patent_doc_number] => 09527913 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Humanized pan-HER antibody compositions' [patent_app_type] => utility [patent_app_number] => 14/398441 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 32563 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10541843 [patent_doc_number] => 09266954 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-23 [patent_title] => 'Methods for modulating D1-D2 dopamine receptor coupling and function' [patent_app_type] => utility [patent_app_number] => 13/862010 [patent_app_country] => US [patent_app_date] => 2013-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14699 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13862010 [rel_patent_id] =>[rel_patent_doc_number] =>)